Related Experiment Video

Updated: Jun 19, 2026

Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
07:45

Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection

Published on: September 19, 2025

[Influenza A H1N1 respiratory infection in an intensive care unit in Argentina]

G Caprotta1, P González Crotti, Y Primucci

  • 1Unidad de Cuidados Intensivos Pediátricos, Hospital de Trauma y Emergencia Dr Federico Abete, Malvinas Argentinas, Buenos Aires, Argentina. gcapro@gmail.com

Anales De Pediatria (Barcelona, Spain : 2003)
|October 20, 2009
PubMed

Insights

During the 2009 Influenza A H1N1 pandemic, critical pediatric cases showed severe respiratory distress requiring mechanical ventilation. This study highlights a 50% mortality rate in pediatric intensive care unit admissions for H1N1.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease epidemiology
  • Virology

Context:

  • The 2009 Influenza A H1N1 pandemic presented with aggressive manifestations in children.
  • Some pediatric cases necessitated intensive care unit admission.
  • Understanding the clinical behavior of critical pediatric H1N1 cases is crucial.

Purpose:

  • To describe the initial presentation and clinical behavior of critical pediatric patients with Influenza A H1N1.
  • To analyze the outcomes of pediatric patients admitted to a Pediatric Intensive Care Unit (PICU) during the pandemic.

Summary:

  • An observational, descriptive, and retrospective study was conducted in a 20-bed PICU.
  • Twenty out of 113 tested patients (17.7%) were confirmed positive for Influenza A H1N1.
  • Ninety-five percent of these pediatric patients required mechanical ventilation, with 90% experiencing respiratory distress.

Impact:

  • The study identified severe respiratory disease requiring mechanical ventilation in confirmed pediatric H1N1 cases.
  • A significant mortality rate of 50% was observed in the studied pediatric population.
  • Findings underscore the severity of H1N1 in critically ill children and inform intensive care management strategies.
Abstract

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...